Notably, a multi-enzyme co-expression nanoplatform integrating lipoxygenase (LOX) and phospholipase A2 (PLA2) has been developed, synergistically inducing immunogenic ferroptosis and upregulating AA expression to enhance CD8+ T cell-mediated anti-tumor immunity. Here, LOX is linked to neoplasm.